Skip to content

Top gainers Top losers Most active Market sectors Heatmap Treasury rates

Earnings calendar IPO calendar Ex-dividend calendar Economic calendar

Congress trades Insider trades Analyst upgrades & downgrades

Screener Compare Backtester

Valuation Fundamentals

Watchlist Portfolio

⌕/

Markets

Stocks Gainers Losers Most active Market sectors Heatmap Earnings calendar Congress trades Insider trades Analyst upgrades/downgrades IPO calendar Ex-dividend calendar

Tools

Screener Compare stocks Returns backtester Portfolio tracker Watchlist Embeddable widget

Metrics

Valuation Fundamentals

Popular lists

Best dividend stocks Best value stocks Largest companies Lowest P/E stocks

Collections

All lists & collections US stocks Japanese stocks Chinese stocks Hong Kong stocks South Korean stocks Taiwanese stocks Canadian stocks UK stocks European stocks Magnificent 7 AI stocks Semiconductor stocks

Compare

Compare stocks Finviz alternative Koyfin alternative TradingView alternative StockAnalysis alternative

Learn

Investing glossary Help & guide

StockMarketCapDocs Token Terms PrivacyData for information only, not investment advice.

◆

Kymera Therapeutics, Inc. (KYMR) News - StockMarketCap

Stocks›Kymera Therapeutics, Inc.☆

● At closeAs of Jul 2, 2026

Kymera Therapeutics, Inc.

KYMR✓

HealthcareBiotechnologyNASDAQ

$113.51-0.60%

$9.34BMarket cap

-32.04xP/E ratio

780.18KVolume (24h)

Overview Forecast Valuation Financials Technical Dividends Smart money News

Price

$113.51

-$0.69 (-0.60%) · 24h

Key metrics

Market cap$9.34B+46.13%

Enterprise value$9.37B

Volume (24h)780.18K

P/E ratio (TTM)-32.04x

P/S ratio (TTM)183.34x

Dividend yield0.00%

Shares outstanding82.26M

Trading range

Previous close$114.20

Day range$109.28 - $115.47

52-week range$36.65 - $130.05

Kymera Therapeutics, Inc. (KYMR) operates in the Biotechnology industry within the Healthcare sector, listed on NASDAQ.

Similar stocks

Eli Lilly and Company+1.57%

Johnson & Johnson+3.57%

AbbVie Inc.+3.99%

UnitedHealth Group Incorporated-0.28%

Roche Holding AG+3.89%

Merck & Co., Inc.+3.31%

Latest news